Who owns Harvard Bioscience?
- Ticker: HBIO
- CUSIP Number: 416906105
Tip: Access positions for across all investors
Analyze quarterly positions in Harvard Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Harvard Bioscience stock
Who bought or sold Harvard Bioscience this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 1.9M | $1.3M | 4% | Dec 2025 |
|
| Renaissance Technologies | 1.0M | $683k | 18% | Dec 2025 |
|
| Nano Cap New Millennium Growth Fund | 600k | $401k | 100% | Dec 2025 |
|
| State Street Corporation | 149k | $100k | 0% | Dec 2025 |
|
| Susquehanna International | 140k | $94k | 66% | Dec 2025 |
|
| Meros Investment Management | 119k | $577k | -90% | Mar 2026 |
|
| Northern Trust | 92k | $62k | -37% | Dec 2025 |
|
| Virtu Financial | 60k | $40k | 100% | Dec 2025 |
|
| GAMCO Asset Management | 57k | $38k | 100% | Dec 2025 |
|
| XTX Topco | 39k | $26k | 100% | Dec 2025 |
|
| Gabelli Funds | 39k | $26k | 0% | Dec 2025 |
|
| FMR | 33k | $22k | -28% | Dec 2025 |
|
| Qube Research & Technologies | 17k | $11k | -54% | Dec 2025 |
|
| Simplex Trading | 14k | $9.2k | 402% | Dec 2025 |
|
| Tower Research Capital | 2.4k | $1.6k | -72% | Dec 2025 |
|
| CWM | 54.00 | $0 | -26% | Dec 2025 |
|
| Financial Connections Group | 30.00 | $0 | -90% | Mar 2026 |
|
| Barclays | 21.00 | $14.000700 | 2000% | Dec 2025 |
|
Who sold out of Harvard Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Weber Capital Management | Dec 2025 | 3.2M | $2.1M |
| Acadian Asset Management | Dec 2025 | 1.8M | $1.2M |
| Corsair Capital Management | Dec 2025 | 1.1M | $742k |
| Two Sigma Investments | Dec 2025 | 1.0M | $677k |
| Two Sigma Advisers | Dec 2025 | 879k | $588k |
| BlackRock | Dec 2025 | 622k | $416k |
| Granahan Investment Management | Sep 2025 | 604k | $265k |
| Millennium Management | Dec 2025 | 546k | $365k |
| Geode Capital Management | Dec 2025 | 461k | $308k |
| Jane Street | Dec 2025 | 445k | $298k |
| Portolan Capital Management | Dec 2025 | 410k | $274k |
| Williams & Novak | Dec 2025 | 349k | $233k |
| Essex Investment Management | Dec 2025 | 185k | $124k |
| Rbf Capital | Dec 2025 | 160k | $107k |
| Assenagon Asset Management | Dec 2025 | 139k | $93k |
| Bank of New York Mellon | Dec 2025 | 126k | $84k |
| Citadel Advisors | Dec 2025 | 62k | $42k |
| Goldman Sachs Group | Dec 2025 | 50k | $33k |
| Pasadena Private Wealth | Dec 2025 | 45k | $30k |
| Legato Capital Management | Dec 2025 | 44k | $29k |
| Callan Family Office | Dec 2025 | 30k | $20k |
| Dimensional Fund Advisors | Dec 2025 | 28k | $19k |
| Greenwood Capital Associates | Dec 2025 | 28k | $19k |
| Group One Trading | Dec 2025 | 26k | $17k |
| Abel Hall | Dec 2025 | 25k | $17k |
| UBS Group | Dec 2025 | 21k | $14k |
| Two Sigma Securities | Dec 2025 | 18k | $12k |
| Morgan Stanley | Dec 2025 | 17k | $11k |
| JustInvest | Dec 2025 | 17k | $11k |
| Point72 Asset Management | Dec 2025 | 15k | $9.8k |
| Camden Capital | Dec 2025 | 14k | $9.1k |
| Bridgeway Capital Management | Sep 2025 | 13k | $5.5k |
| Ethic | Dec 2025 | 11k | $7.3k |
| Balboa Wealth Partners | Dec 2025 | 10k | $6.7k |
| SBI Securities | Dec 2025 | 8.7k | $5.8k |
| Royal Bank of Canada | Sep 2025 | 7.4k | $0 |
| Brown Shipley& Co | Dec 2025 | 4.8k | $3.2k |
| NISA Investment Advisors | Dec 2025 | 2.3k | $1.5k |
| Federated Investors | Dec 2025 | 1.7k | $1.1k |
| Jpmorgan Chase & Co | Sep 2025 | 1.6k | $717.988200 |
| Rialto Wealth Management | Sep 2025 | 1.1k | $474.991400 |
| Bnp Paribas Arbitrage, Snc | Dec 2025 | 680.00 | $454.988000 |
| Pnc Financial Services | Dec 2025 | 144.00 | $96.004800 |
| SHP Wealth Management | Dec 2025 | 100.00 | $67.000000 |